Ritalinic acid

• Description :

  Ritalinic acid (Ritalinate) is the main inactive urinary metabolite of Methylphenidate. Methylphenidate has the potential for attention-deficit hyperactivity disorder and narcolepsy research[1].

• Product Name Alternative :

  Ritalinate

• UNSPSC :

  12352005

• Hazard Statement :

  H319

• Target :

  Drug Metabolite

• Type :

  Reference compound

• Related Pathways :

  Metabolic Enzyme/Protease

• Applications :

  Metabolism-sugar/lipid metabolism

• Field of Research :

  Others

• Assay Protocol :

  https://www.medchemexpress.com/ritalinic-acid.html

• Purity :

  99.94

• Solubility :

  H2O : 4.03 mg/mL (ultrasonic; adjust pH to 12 with 1 M NaOH)

• Smiles :

  C2=C(C(C1CCCCN1)C(O)=O)C=CC=C2

• Molecular Formula :

  C13H17NO2

• Molecular Weight :

  219.28

• Precautions :

  H319

• References & Citations :

  [1]Ricardo Jorge Dinis-Oliveira, et al. Metabolomics of Methylphenidate and Ethylphenidate: Implications in Pharmacological and Toxicological Effects. Eur J Drug Metab Pharmacokinet. 2017 Feb;42 (1) :11-16.

• Shipping Conditions :

  Room Temperature

• Storage Conditions :

  -20°C, 3 years; 4°C, 2 years (Powder)

• Scientific Category :

  Reference compound1

• Clinical Information :

  No Development Reported

• CAS Number :

  [19395-41-6]